You have 9 free searches left this month | for more free features.

Hormonal Ablation

Showing 1 - 25 of 4,658

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Fibroids Before and During Non-surgical Therapy and/or Expectant

Recruiting
  • Fibroid Uterus
  • Questionnaire
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Feb 21, 2023

Menstrual Bleeding, Heavy Trial (NovaSure ablation)

Not yet recruiting
  • Menstrual Bleeding, Heavy
  • NovaSure ablation
  • (no location specified)
May 11, 2023

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)

Active, not recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Anchorage, Alaska
  • +342 more
Jan 29, 2023

Prostate Cancer Trial in Worldwide (MRI-guided Transurethral Ultrasound Ablation)

Recruiting
  • Prostate Cancer
  • MRI-guided Transurethral Ultrasound Ablation
  • Los Angeles, California
  • +14 more
Sep 12, 2022

Prostate Cancer Trial in Nijmegen (Focal laser ablation)

Recruiting
  • Prostate Cancer
  • Focal laser ablation
  • Nijmegen, Netherlands
    Radboudumc
Sep 21, 2021

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Prostate Cancer Trial (Irreversible Electroporation (IRE))

Not yet recruiting
  • Prostate Cancer
  • Irreversible Electroporation (IRE)
  • (no location specified)
Aug 22, 2022

Thyroid Nodule Trial in New York (Mygen V-1000 RF system)

Recruiting
  • Thyroid Nodule
  • Mygen V-1000 RF system
  • New York, New York
    Northwell Health Physician Partners
Jun 13, 2023

Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)

Terminated
  • Adenocarcinoma of the Prostate
  • Muscadine Plus
  • Placebos
  • Duarte, California
  • +12 more
Dec 6, 2022

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Hepatocellular Carcinoma Trial in Seoul (Microwave ablation)

Recruiting
  • Hepatocellular Carcinoma
  • Microwave ablation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 10, 2023

Atrial Fibrillation, Cathter Ablation, Endpoint Trial in Shanghai (AF-termination Group, Prespecified-ablation Group)

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • AF-termination Group
  • Prespecified-ablation Group
  • Shanghai, China
  • +1 more
Jun 19, 2023

Persistent Atrial Fibrillation, Pulsed-field Ablation Trial in Ceské Budejovice (pulsed-field ablation)

Active, not recruiting
  • Persistent Atrial Fibrillation
  • Pulsed-field Ablation
  • pulsed-field ablation
  • České Budějovice, Czechia
    Ceske Budejovice Hospital
Jun 30, 2023

Arrhythmias, Cardiac, Paroxysmal Atrial Fibrillation Trial in China (Pulsed Field Ablation (PFA) Therapy, Radiofrequency

Not yet recruiting
  • Arrhythmias, Cardiac
  • Paroxysmal Atrial Fibrillation
  • Pulsed Field Ablation (PFA) Therapy
  • Radiofrequency Ablation(RAF)Therapy
  • Beijing, Beijing, China
  • +9 more
Aug 26, 2023

Paroxysmal Atrial Fibrillation Trial (QDOT MicroTM catheter, AI-guided ablation only for PVI)

Not yet recruiting
  • Paroxysmal Atrial Fibrillation
  • QDOT MicroTM catheter
  • AI-guided ablation only for PVI
  • (no location specified)
Aug 13, 2023

Vulvovaginal Atrophy Trial in Ankara (Hyaluronic acid vaginal gel, Estrogen vaginal use form)

Completed
  • Vulvovaginal Atrophy
  • Hyaluronic acid vaginal gel
  • Estrogen vaginal use form
  • Ankara, Çankaya, Turkey
    Turkey
Nov 17, 2023

Obesity, Obesity, Morbid, Obesity, Primary Trial in Boston (Blood Collection, Urine Collection, Tissue Sample Collection)

Not yet recruiting
  • Obesity
  • +16 more
  • Blood Collection
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 23, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Radical Prostatectomy
  • TULSA Procedure
  • Tarzana, California
  • +7 more
Aug 10, 2022

Ventricular Arrythmia Trial in Warsaw (Ablation)

Recruiting
  • Ventricular Arrythmia
  • Ablation
  • Warsaw, Poland
    Department of Cardiology, Postgraduate Medical School, Grochowsk
Jan 21, 2023

Optimized Strategies and Workflows for Catheter Ablation of

Not yet recruiting
  • Atrial Fibrillation
  • Pulmonary vein isolation plus superior vena cava isolation
  • PVI, superior vena cava isolation, and linear ablation of linear ablations of the mitral isthmus, roofline and posterior wall line of the left atrium, and cavotricuspid isthmus
  • Zhengzhou, Henan, China
    Department of Cardiology, Henan Provincial People's Hospital
Nov 28, 2023

High Power Short Duration Ablation Compared to Moderate Power

Completed
  • Paroxysmal Atrial Fibrillation
  • High power short duration ablation
  • München, Germany
    Deutsches Herzzentrum München
Jul 17, 2023

Obesity, Adiposity Trial in Double Bay (Hybrid Argonplasma coagulation (HAPC))

Recruiting
  • Obesity
  • Adiposity
  • Hybrid Argonplasma coagulation (HAPC)
  • Double Bay, New South Wales, Australia
    The Bariatric & Metabolic Institute The BMI Clinic
Jan 24, 2023

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022